tirzepatide approved for Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Introducing Tirzepatide NOW AVAILABLE at

It works by mimicking the GLP-1 hormone your body naturally produces to help control blood sugar levels

This co-agonism triggers intracellular cyclic AMP (cAMP) cascades in pancreatic beta cells, promoting glucose-stimulated insulin secretion through two complementary yet mechanistically distinct pathways

Kansas, United States Quick and easy purchase and fast delivery United States Product itself is great

Activating both pathways simultaneously may provide metabolic benefits beyond those of GLP-1 activation alone supporting appetite control and blood sugar management at the same time

We emphasize safety and long-term success

FDA clears Abbotts FreeStyle Libre 2 and FreeStyle Libre 3 sensors for integration with automated insulin delivery systems